ALK and lung adenocarcinoma: The tumor specimen was also examined as an advanced primary lung adenocarcinoma and assessed for the following tumor markers: epidermal growth factor receptor (EGFR) mutation, anaplastic lymphoma kinase (ALK) rearrangement, ROS1 rearrangement, and programmed death-ligand 1 (PD-L1) expression.